Allergan and Gedeon Richter Plc. to Present Data on Cariprazine at the American Psychiatric Association (APA) Annual Meeting

Go back to Allergan and Gedeon Richter Plc. to Present Data on Cariprazine at the American Psychiatric Association (APA) Annual Meeting

Mizuho Securities Remains Sidelined on Allergan (AGN) following 1Q Earnings; PT to $232

May 13, 2016 6:52 AM EDT

Mizuho Securities maintained a Neutral rating on Allergen (NYSE: AGN), and cut the price target to $232.00 (from $250.00), following the company's 1Q earnings report. AGN reported $3.8B in revenues and EPS of $3.04 vs. consensus estimates $3.95B and $3.00. Management reiterated its FY16 revenue guidance of... More